BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014;13:419-28. [PMID: 24581702 DOI: 10.1016/S1474-4422(14)70003-1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Charidimou A, Boulouis G, Frosch MP, Baron J, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, Calviere L, Caparros F, Casolla B, Cordonnier C, Delisle M, Deramecourt V, Dichgans M, Gokcal E, Herms J, Hernandez-guillamon M, Jäger HR, Jaunmuktane Z, Linn J, Martinez-ramirez S, Martínez-sáez E, Mawrin C, Montaner J, Moulin S, Olivot J, Piazza F, Puy L, Raposo N, Rodrigues MA, Roeber S, Romero JR, Samarasekera N, Schneider JA, Schreiber S, Schreiber F, Schwall C, Smith C, Szalardy L, Varlet P, Viguier A, Wardlaw JM, Warren A, Wollenweber FA, Zedde M, van Buchem MA, Gurol ME, Viswanathan A, Al-shahi Salman R, Smith EE, Werring DJ, Greenberg SM. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study. The Lancet Neurology 2022;21:714-25. [DOI: 10.1016/s1474-4422(22)00208-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Best JG, Cardus B, Klijn CJM, Lip G, Seiffge DJ, Smith EE, Werring DJ. Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges. J Neurol Neurosurg Psychiatry 2022:jnnp-2020-325249. [PMID: 35728935 DOI: 10.1136/jnnp-2020-325249] [Reference Citation Analysis]
3 Charidimou A. Cerebrospinal Fluid Biomarkers for Cerebral Amyloid Angiopathy Diagnosis. J Alzheimers Dis 2022. [PMID: 35527557 DOI: 10.3233/JAD-220133] [Reference Citation Analysis]
4 Vargas-george S, Dave KR. Models of cerebral amyloid angiopathy-related intracerebral hemorrhage. Brain Hemorrhages 2022. [DOI: 10.1016/j.hest.2022.05.001] [Reference Citation Analysis]
5 Grangeon L, Paquet C, Guey S, Zarea A, Martinaud O, Rotharmel M, Maltête D, Quillard-muraine M, Nicolas G, Charbonnier C, Chabriat H, Wallon D, Shams M. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy. JAD 2022. [DOI: 10.3233/jad-215208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Onomura H, Shimizu T, Kobayashi R, Suzuki J, Nakai N, Okuda S, Ito Y. Palinopsia as an initial symptom of cerebral amyloid angiopathy-related inflammation. eNeurologicalSci 2021;25:100375. [PMID: 34765753 DOI: 10.1016/j.ensci.2021.100375] [Reference Citation Analysis]
7 Fotiadis P, Pasi M, Charidimou A, Warren AD, Schwab KM, Rosand J, van der Grond J, van Buchem MA, Viswanathan A, Gurol ME, Greenberg SM; Alzheimer’s Disease Neuroimaging Initiative. Decreased Basal Ganglia Volume in Cerebral Amyloid Angiopathy. J Stroke 2021;23:223-33. [PMID: 34102757 DOI: 10.5853/jos.2020.04280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Smith EE, Charidimou A, Ayata C, Werring DJ, Greenberg SM. Cerebral Amyloid Angiopathy-Related Transient Focal Neurologic Episodes. Neurology 2021;97:231-8. [PMID: 34016709 DOI: 10.1212/WNL.0000000000012234] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Banerjee G, Ambler G, Keshavan A, Paterson RW, Foiani MS, Toombs J, Heslegrave A, Dickson JC, Fraioli F, Groves AM, Lunn MP, Fox NC, Zetterberg H, Schott JM, Werring DJ. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy. J Alzheimers Dis 2020;74:1189-201. [PMID: 32176643 DOI: 10.3233/JAD-191254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
10 Zhang Q, Wang A, Meng X, Liao X, Zhang Y, Hou H, Niu L, Li R, Guo W, Wang Y. Vascular Risk Factors, Imaging, and Outcomes in Transient Ischemic Attack/Ischemic Stroke Patients with Neuroimaging Evidence of Probable/Possible Cerebral Amyloid Angiopathy. Oxid Med Cell Longev 2021;2021:9958851. [PMID: 33995827 DOI: 10.1155/2021/9958851] [Reference Citation Analysis]
11 Li X. The association of low-grade albuminuria with incident nonalcoholic fatty liver disease and non-invasive markers of liver fibrosis. Liver Int 2021;41:220. [PMID: 33034103 DOI: 10.1111/liv.14693] [Reference Citation Analysis]
12 Cisternas P, Taylor X, Perkins A, Maldonado O, Allman E, Cordova R, Marambio Y, Munoz B, Pennington T, Xiang S, Zhang J, Vidal R, Atwood B, Lasagna-Reeves CA. Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy. Aging Cell 2020;19:e13233. [PMID: 32914559 DOI: 10.1111/acel.13233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hachinski V, Einhäupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, Nishimura N, Schaffer CB, Whitehead SN, Black SE, Østergaard L, Wardlaw J, Greenberg S, Friberg L, Norrving B, Rowe B, Joanette Y, Hacke W, Kuller L, Dichgans M, Endres M, Khachaturian ZS. Preventing dementia by preventing stroke: The Berlin Manifesto. Alzheimers Dement 2019;15:961-84. [PMID: 31327392 DOI: 10.1016/j.jalz.2019.06.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 39.5] [Reference Citation Analysis]
14 Kulesh AA, Gorst NK, Kuzina NV, Drobakha VE, Shestakov VV, Karakulova YV. Amyloid angiitis and progressive cortical superficial siderosis as aggressive phenotypes of cerebral amyloid angiopathy: principles of rational management. РНЖ 2020;24:29-38. [DOI: 10.30629/2658-7947-2019-24-6-29-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 2020;16:30-42. [PMID: 31827267 DOI: 10.1038/s41582-019-0281-2] [Cited by in Crossref: 100] [Cited by in F6Publishing: 168] [Article Influence: 33.3] [Reference Citation Analysis]
16 Charidimou A, Boulouis G, Greenberg SM, Viswanathan A. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis. Neurology 2019;93:e2192-202. [PMID: 31732564 DOI: 10.1212/WNL.0000000000008590] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
17 Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A. APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms. Neurology 2019;93:e358-71. [PMID: 31243071 DOI: 10.1212/WNL.0000000000007818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
18 Chen SJ, Tsai HH, Tsai LK, Tang SC, Lee BC, Liu HM, Yen RF, Jeng JS. Advances in cerebral amyloid angiopathy imaging. Ther Adv Neurol Disord 2019;12:1756286419844113. [PMID: 31105769 DOI: 10.1177/1756286419844113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M. Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives. Int J Mol Sci 2019;20:E2139. [PMID: 31052203 DOI: 10.3390/ijms20092139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
20 van Veluw SJ, Reijmer YD, van der Kouwe AJ, Charidimou A, Riley GA, Leemans A, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy. Neurology 2019;92:e933-43. [PMID: 30700595 DOI: 10.1212/WNL.0000000000007005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
21 Charidimou A, Giese AK, Pasi M, van Veluw SJ, Xiong L, Fotiadis P, Marini S, Schirmer MD, Viswanathan A. Journal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages. Neurology 2018;91:574-7. [PMID: 30224502 DOI: 10.1212/WNL.0000000000006195] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Alamowitch S, Capron J. Angiopathie amyloïde cérébrale sporadique. Pratique Neurologique - FMC 2018;9:122-31. [DOI: 10.1016/j.praneu.2018.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG. The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system? Acta Neuropathol 2018;135:387-407. [PMID: 29428972 DOI: 10.1007/s00401-018-1812-4] [Cited by in Crossref: 285] [Cited by in F6Publishing: 248] [Article Influence: 71.3] [Reference Citation Analysis]
24 Charidimou A, Friedrich JO, Greenberg SM, Viswanathan A. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis. Neurology 2018;90:e754-62. [PMID: 29386280 DOI: 10.1212/WNL.0000000000005030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
25 Greenberg SM, Charidimou A. Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria. Stroke 2018;49:491-7. [PMID: 29335334 DOI: 10.1161/STROKEAHA.117.016990] [Cited by in Crossref: 140] [Cited by in F6Publishing: 158] [Article Influence: 35.0] [Reference Citation Analysis]
26 Valenti R, Reijmer YD, Charidimou A, Boulouis G, Martinez SR, Xiong L, Fotiadis P, Jessel M, Ayres A, Riley G, Pantoni L, Edip Gurol M, Greenberg SM, Viswanathan A. Total small vessel disease burden and brain network efficiency in cerebral amyloid angiopathy. J Neurol Sci 2017;382:10-2. [PMID: 29110998 DOI: 10.1016/j.jns.2017.09.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
27 Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 2017;140:1829-50. [PMID: 28334869 DOI: 10.1093/brain/awx047] [Cited by in Crossref: 169] [Cited by in F6Publishing: 196] [Article Influence: 33.8] [Reference Citation Analysis]
28 Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, Buchem MV, Grond JV, Verbeek MM, Werring DJ. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry 2017;88:982-94. [PMID: 28844070 DOI: 10.1136/jnnp-2016-314697] [Cited by in Crossref: 120] [Cited by in F6Publishing: 107] [Article Influence: 24.0] [Reference Citation Analysis]
29 Greenberg SM. William M. Feinberg Award for Excellence in Clinical Stroke: Big Pictures and Small Vessels. Stroke 2017;48:2628-31. [PMID: 28698255 DOI: 10.1161/STROKEAHA.117.017246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Prats-Sanchez L, Martínez-Domeño A, Camps-Renom P, Delgado-Mederos R, Guisado-Alonso D, Marín R, Dorado L, Rudilosso S, Gómez-González A, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garces M, Abilleira S, Martí-Fàbregas J. Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis. PLoS One 2017;12:e0178284. [PMID: 28640874 DOI: 10.1371/journal.pone.0178284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
31 Charidimou A, Martinez-Ramirez S, Reijmer YD, Oliveira-Filho J, Lauer A, Roongpiboonsopit D, Frosch M, Vashkevich A, Ayres A, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA Neurol 2016;73:994-1001. [PMID: 27366898 DOI: 10.1001/jamaneurol.2016.0832] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 12.8] [Reference Citation Analysis]
32 Farid K, Charidimou A, Baron JC. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update. Neuroimage Clin 2017;15:247-63. [PMID: 28560150 DOI: 10.1016/j.nicl.2017.05.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
33 Saito S, Yamamoto Y, Maki T, Hattori Y, Ito H, Mizuno K, Harada-Shiba M, Kalaria RN, Fukushima M, Takahashi R, Ihara M. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol Commun 2017;5:26. [PMID: 28376923 DOI: 10.1186/s40478-017-0429-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
34 van Veluw SJ, Kuijf HJ, Charidimou A, Viswanathan A, Biessels GJ, Rozemuller AJ, Frosch MP, Greenberg SM. Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy. Acta Neuropathol 2017;133:409-15. [PMID: 27771772 DOI: 10.1007/s00401-016-1635-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
35 Williams RJ, Goodyear BG, Peca S, McCreary CR, Frayne R, Smith EE, Pike GB. Identification of neurovascular changes associated with cerebral amyloid angiopathy from subject-specific hemodynamic response functions. J Cereb Blood Flow Metab 2017;37:3433-45. [PMID: 28145796 DOI: 10.1177/0271678X17691056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 van Veluw SJ, Charidimou A, van der Kouwe AJ, Lauer A, Reijmer YD, Costantino I, Gurol ME, Biessels GJ, Frosch MP, Viswanathan A, Greenberg SM. Microbleed and microinfarct detection in amyloid angiopathy: a high-resolution MRI-histopathology study. Brain 2016;139:3151-62. [PMID: 27645801 DOI: 10.1093/brain/aww229] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 11.3] [Reference Citation Analysis]
37 Gurol ME, Becker JA, Fotiadis P, Riley G, Schwab K, Johnson KA, Greenberg SM. Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study. Neurology 2016;87:2043-9. [PMID: 27605173 DOI: 10.1212/WNL.0000000000003197] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 8.8] [Reference Citation Analysis]
38 Reijmer YD, Fotiadis P, Riley GA, Xiong L, Charidimou A, Boulouis G, Ayres AM, Schwab K, Rosand J, Gurol ME, Viswanathan A, Greenberg SM. Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy. Stroke 2016;47:2470-5. [PMID: 27576378 DOI: 10.1161/STROKEAHA.116.014337] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
39 Yang Y, Kimura-Ohba S, Thompson J, Rosenberg GA. Rodent Models of Vascular Cognitive Impairment. Transl Stroke Res 2016;7:407-14. [PMID: 27498679 DOI: 10.1007/s12975-016-0486-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 7.5] [Reference Citation Analysis]
40 Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease. Acta Neuropathol 2016;132:225-34. [PMID: 27179972 DOI: 10.1007/s00401-016-1580-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
41 Reuter B, Venus A, Heiler P, Schad L, Ebert A, Hennerici MG, Grudzenski S, Fatar M. Development of Cerebral Microbleeds in the APP23-Transgenic Mouse Model of Cerebral Amyloid Angiopathy-A 9.4 Tesla MRI Study. Front Aging Neurosci 2016;8:170. [PMID: 27458375 DOI: 10.3389/fnagi.2016.00170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
42 Al-Shahi Salman R, McGoohan K, Rodrigues M, Dichgans M. Dementia after stroke due to intracerebral haemorrhage. Lancet Neurol 2016;15:779-80. [PMID: 27302345 DOI: 10.1016/S1474-4422(16)30092-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Martí-Fàbregas J, Prats-Sánchez L, Martínez-Domeño A, Camps-Renom P, Marín R, Jiménez-Xarrié E, Fuentes B, Dorado L, Purroy F, Arias-Rivas S, Delgado-Mederos R. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One 2016;11:e0156992. [PMID: 27275863 DOI: 10.1371/journal.pone.0156992] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
44 Reijmer YD, van Veluw SJ, Greenberg SM. Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab 2016;36:40-54. [PMID: 25944592 DOI: 10.1038/jcbfm.2015.88] [Cited by in Crossref: 59] [Cited by in F6Publishing: 73] [Article Influence: 9.8] [Reference Citation Analysis]
45 Rosenberg GA, Wallin A, Wardlaw JM, Markus HS, Montaner J, Wolfson L, Iadecola C, Zlokovic BV, Joutel A, Dichgans M, Duering M, Schmidt R, Korczyn AD, Grinberg LT, Chui HC, Hachinski V. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab 2016;36:6-25. [PMID: 26198175 DOI: 10.1038/jcbfm.2015.172] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 17.3] [Reference Citation Analysis]
46 Bouvy WH, Zwanenburg JJM, Reinink R, Wisse LEM, Luijten PR, Kappelle LJ, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study group. Perivascular spaces on 7 Tesla brain MRI are related to markers of small vessel disease but not to age or cardiovascular risk factors. J Cereb Blood Flow Metab 2016;36:1708-17. [PMID: 27154503 DOI: 10.1177/0271678X16648970] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
47 Switzer AR, McCreary C, Batool S, Stafford RB, Frayne R, Goodyear BG, Smith EE. Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy. Neuroimage Clin 2016;11:461-7. [PMID: 27104140 DOI: 10.1016/j.nicl.2016.02.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
48 Reuter B, Venus A, Grudzenski S, Heiler P, Schad L, Staufenbiel M, Hennerici MG, Fatar M. Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach. Int J Mol Sci 2016;17:E126. [PMID: 26797603 DOI: 10.3390/ijms17010126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Charidimou A. Cerebral Amyloid Angiopathy-Related Inflammation Biomarkers: Where are we Now? J Alzheimers Dis 2016;50:9-11. [PMID: 26756457 DOI: 10.3233/JAD-151042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Charidimou A, Boulouis G, Haley K, Auriel E, van Etten ES, Fotiadis P, Reijmer Y, Ayres A, Vashkevich A, Dipucchio ZY, Schwab KM, Martinez-Ramirez S, Rosand J, Viswanathan A, Greenberg SM, Gurol ME. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2016;86:505-11. [PMID: 26747886 DOI: 10.1212/WNL.0000000000002362] [Cited by in Crossref: 77] [Cited by in F6Publishing: 95] [Article Influence: 12.8] [Reference Citation Analysis]
51 Li XQ, Su DF, Chen HS, Fang Q. Clinical Neuropathological Analysis of 10 Cases of Cerebral Amyloid Angiopathy-Related Cerebral Lobar Hemorrhage. J Korean Neurosurg Soc 2015;58:30-5. [PMID: 26279810 DOI: 10.3340/jkns.2015.58.1.30] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
52 Kövari E, Charidimou A, Herrmann FR, Giannakopoulos P, Bouras C, Gold G. No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy. Acta Neuropathol Commun 2015;3:49. [PMID: 26268348 DOI: 10.1186/s40478-015-0228-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
53 Charidimou A, Nicoll JA, McCarron MO. Thrombolysis-related intracerebral hemorrhage and cerebral amyloid angiopathy: accumulating evidence. Front Neurol 2015;6:99. [PMID: 26005432 DOI: 10.3389/fneur.2015.00099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
54 Bridges LR, Andoh J, Lawrence AJ, Khoong CHL, Poon W, Esiri MM, Markus HS, Hainsworth AH. Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol 2014;73:1026-33. [PMID: 25289893 DOI: 10.1097/NEN.0000000000000124] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
55 Reijmer YD, Fotiadis P, Martinez-Ramirez S, Salat DH, Schultz A, Shoamanesh A, Ayres AM, Vashkevich A, Rosas D, Schwab K, Leemans A, Biessels GJ, Rosand J, Johnson KA, Viswanathan A, Gurol ME, Greenberg SM. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain 2015;138:179-88. [PMID: 25367025 DOI: 10.1093/brain/awu316] [Cited by in Crossref: 104] [Cited by in F6Publishing: 117] [Article Influence: 13.0] [Reference Citation Analysis]